• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Ridgetech Inc.

    6/4/25 4:47:24 PM ET
    $RDGT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $RDGT alert in real time by email
    6-K 1 ea0244707-6k_ridgetech.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

     

     

    FORM 6-K

     

     

     

    REPORT OF FOREIGN PRIVATE ISSUER
    PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
    SECURITIES EXCHANGE ACT OF 1934

     

    For the month of June 2025

     

    Commission File Number: 001-40724

     

     

     

    RIDGETECH, INC.
    (Translation of registrant’s name into English)

     

     

     

    5th Floor, Building 6, No. 100, 18th Street, Baiyang Sub-district,

    Qiantang District, Hangzhou City, Zhejiang Province, People’s Republic of China, 310018
    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

     

    Form 20-F ☒     Form 40-F ☐

     

     

     

     

     

     

    Ridgetech, Inc. (formerly known as China Jo-Jo Drugstores, Inc.), a Cayman Islands exempted company (the “Company”) furnishes under the cover of Form 6-K the following:

     

    Completion of Capital Reduction and Share Subdivision.

     

    As previously disclosed, at the Company’s annual general meeting of shareholders (the “Annual Meeting”) held on February 25, 2025, the shareholders of the Company approved, among others, by a special resolution that the par value of each issued, ordinary share of the Company be reduced from US$0.24 to US$0.001 by cancelling the paid-up capital to the extent of the difference between US$0.24 and such new par value (the “Capital Reduction”), and immediately following the Capital Reduction, each of the authorized but unissued ordinary shares of the Company of par value of US$0.24 be sub-divided (the “Share Subdivision”) into 240 new ordinary shares of par value of US$0.001 each, subject to an order by the Grand Court of the Cayman Islands (the “Grand Court”) confirming the Capital Reduction and certain other conditions set forth in the proxy statement provided to shareholders for the Annual Meeting. The shareholders of the Company further approved by a special resolution at the Annual Meeting the adoption by the Company of one or more newly amended and restated memorandum and articles of association to reflect the Capital Reduction and the Share Subdivision.

     

    On April 10, 2025, the Company presented a petition to the Grand Court for confirmation of the Capital Reduction and the Share Subdivision. On May 28, 2025, the Grant Court granted the order confirming the Capital Reduction and the Share Subdivision (the “Court Order”). On May 28, 2025, the Company completed the registration with the Registrar of Companies of the Cayman Islands of the Court Order, the Annual Meeting minutes regarding the Capital Reduction and the Share Subdivision and the certificate for the Capital Reduction. On May 29, 2025, a copy of the Fourth Amended and Restated Memorandum and Articles of Association reflecting the Capital Reduction and the Share Subdivision was filed with the Cayman Islands General Registry, a copy of which is attached hereto as exhibit 3.1. The Capital Reduction and the Share Subdivision became effective on May 28, 2025. Pursuant to the Fourth Amended and Restated Memorandum and Articles, the authorized share capital of the Company now has become US$36,010,000 divided into (i) 36,000,000,000 ordinary shares of a par value of US$0.001 each and (ii) 10,000,000 preferred shares of a par value of US$0.001 each.

     

    Exhibit No.   Description of Exhibit
    3.1   Fourth Amended and Restated Memorandum and Articles of Ridgetech, Inc.

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    Date: June 4, 2025 RIDGETECH, INC.
      By: /s/ Ming Zhao
      Name: Ming Zhao
      Title: Interim Chief Executive Officer and Chief Financial Officer

     

     

    2

     

     

    Get the next $RDGT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RDGT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RDGT
    SEC Filings

    See more
    • SEC Form 6-K filed by Ridgetech Inc.

      6-K - Ridgetech Inc. (0001856084) (Filer)

      6/4/25 4:47:24 PM ET
      $RDGT
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples